Bogart Wealth, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bogart Wealth, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$23,000
+2200.0%
524
+2083.3%
0.00%
Q1 2022$1,000
-98.9%
24
-98.8%
0.00%
-100.0%
Q4 2021$89,000
+15.6%
2,0070.0%0.01%0.0%
Q3 2021$77,000
-3.8%
2,0070.0%0.01%
-11.1%
Q2 2021$80,000
+11.1%
2,0070.0%0.01%
-10.0%
Q1 2021$72,000
-1.4%
2,0070.0%0.01%
-28.6%
Q4 2020$73,000
-2.7%
2,0070.0%0.01%
-17.6%
Q3 2020$75,000
-8.5%
2,0070.0%0.02%
-10.5%
Q2 2020$82,000
+7.9%
2,0070.0%0.02%
-9.5%
Q1 2020$76,000
-49.7%
2,007
-37.4%
0.02%
-56.2%
Q4 2019$151,000
+10.2%
3,2070.0%0.05%
-28.4%
Q3 2019$137,000
+2.2%
3,207
-4.3%
0.07%
-17.3%
Q2 2019$134,000
-8.8%
3,352
-5.0%
0.08%
+14.1%
Q1 2019$147,000
-8.1%
3,529
-16.1%
0.07%
-11.2%
Q4 2018$160,000
-92.1%
4,206
-91.7%
0.08%
-93.2%
Q3 2018$2,028,000
+6.6%
50,496
+7.0%
1.17%
+1.5%
Q2 2018$1,902,000
+4.8%
47,208
+3.7%
1.16%
+10.3%
Q1 2018$1,815,000
+26.4%
45,532
+12.4%
1.05%
+14.0%
Q4 2017$1,436,000
-2.2%
40,495
+11.9%
0.92%
-15.4%
Q3 2017$1,469,000
-4.9%
36,185
+1.0%
1.09%
+9.8%
Q2 2017$1,544,000
+43.8%
35,816
+40.6%
0.99%
+38.7%
Q1 2017$1,074,000
+11.3%
25,478
+1.7%
0.71%
+9.2%
Q4 2016$965,00025,0590.65%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders